171 related articles for article (PubMed ID: 38438972)
1. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract][Full Text] [Related]
2. Construction of web
Zhan G; Cao P; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
[TBL] [Abstract][Full Text] [Related]
5. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
[TBL] [Abstract][Full Text] [Related]
6. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
[TBL] [Abstract][Full Text] [Related]
7. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study.
Shen J; Zhou Y; Yu B; Zhao K; Ding Y
Eur J Surg Oncol; 2023 Oct; 49(10):106966. PubMed ID: 37365056
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of web-based prognostic nomograms for massive hepatocellular carcinoma (≥10 cm): A retrospective study based on the SEER database.
Huang G; Lin Q; Yin P; Mao K; Zhang J
Cancer Med; 2023 Jun; 12(12):13167-13181. PubMed ID: 37102245
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database.
Zhang H; Du X; Dong H; Xu W; Zhou P; Liu S; Qing X; Zhang Y; Yang M; Zhang Y
BMC Gastroenterol; 2022 Jul; 22(1):348. PubMed ID: 35854221
[TBL] [Abstract][Full Text] [Related]
11. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.
He T; Chen T; Liu X; Zhang B; Yue S; Cao J; Zhang G
Front Public Health; 2021; 9():789026. PubMed ID: 35096742
[No Abstract] [Full Text] [Related]
12. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
13. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort.
Zhan G; Peng H; Zhou L; Jin L; Xie X; He Y; Wang X; Du Z; Cao P
Front Endocrinol (Lausanne); 2023; 14():1070396. PubMed ID: 36798659
[TBL] [Abstract][Full Text] [Related]
14. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
[TBL] [Abstract][Full Text] [Related]
16. Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study.
Wang L; Peng JL; Wu JZ
Medicine (Baltimore); 2023 Mar; 102(13):e33319. PubMed ID: 37000113
[TBL] [Abstract][Full Text] [Related]
17. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and survival prediction in hepatocellular carcinoma: development and validation of a novel nomogram based on the SEER database.
Huang S; Zhu Z; Ruan Y; Zhang F; Xu Y; Jin L; Lopez-Lopez V; Merle P; Lu G; Li L
J Gastrointest Oncol; 2023 Aug; 14(4):1817-1829. PubMed ID: 37720431
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Nomogram to Predict Cancer-Specific Survival for Middle-Aged Patients With Early-Stage Hepatocellular Carcinoma.
Wen C; Tang J; Luo H
Front Public Health; 2022; 10():848716. PubMed ID: 35296046
[TBL] [Abstract][Full Text] [Related]
20. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]